Mechlorethamine [clinicaltrials_resource:e93e5321bb897b8d32d99c47853ecbc9]
Radiation Therapy or No Radiation Therapy Following Chemotherapy in Treating Patients With Stage III or Stage IV Hodgkin's Disease [clinicaltrials:NCT00002462]clinicaltrials:NCT00002463Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease [clinicaltrials:NCT00002714]Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma [clinicaltrials:NCT00002715]Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection [clinicaltrials:NCT00003262]Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00003389]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma [clinicaltrials:NCT00041210]clinicaltrials:NCT00168064clinicaltrials:NCT00303849clinicaltrials:NCT00352027Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma [clinicaltrials:NCT00379041]An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides [clinicaltrials:NCT00535470]Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma [clinicaltrials:NCT00567567]clinicaltrials:NCT00574496Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients [clinicaltrials:NCT00792467]Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma [clinicaltrials:NCT00793572]Experimental Denture Pastes [clinicaltrials:NCT01237795]Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT01256398]Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma [clinicaltrials:NCT01842308]Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma [clinicaltrials:NCT02097134]JAK-2 Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis [clinicaltrials:NCT02251821]clinicaltrials:NCT02289612clinicaltrials:NCT02296164Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma [clinicaltrials:NCT02443077]clinicaltrials:NCT02473601clinicaltrials:NCT02504359
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Mechlorethamine [clinicaltrials_resource:e93e5321bb897b8d32d99c47853ecbc9]
Bio2RDF identifier
e93e5321bb897b8d32d99c47853ecbc9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e93e5321bb897b8d32d99c47853ecbc9
identifier
clinicaltrials_resource:e93e5321bb897b8d32d99c47853ecbc9
title
Mechlorethamine
@en
type
label
Mechlorethamine [clinicaltrials_resource:e93e5321bb897b8d32d99c47853ecbc9]
@en